S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
NASDAQ:CHNG

Change Healthcare - CHNG Price Target & Analyst Ratings

$27.49
0.00 (0.00%)
(As of 10/3/2022 12:00 AM ET)
Add
Compare
Today's Range
$27.49
$27.49
50-Day Range
$23.84
$27.49
52-Week Range
$18.97
$27.59
Volume
3 shs
Average Volume
12.36 million shs
Market Capitalization
$9.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.75

Change Healthcare Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$27.75
0.95% Upside
High Prediction$27.75
Average Prediction$27.75
Low Prediction$27.75
TypeCurrent
10/5/21 to 10/5/22
1 Month Ago
9/5/21 to 9/5/22
3 Months Ago
7/7/21 to 7/7/22
1 Year Ago
10/5/20 to 10/5/21
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
13 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$27.75$27.31$27.00$24.81
Predicted Upside0.95% Upside14.97% Upside15.86% Upside10.79% Upside
Get Change Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CHNG and its competitors with MarketBeat's FREE daily newsletter.


CHNG Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CHNG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Change Healthcare Stock vs. The Competition

TypeChange HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.17
2.68
2.49
Consensus RatingHoldBuyHold
Predicted Upside0.95% Upside1,093.04% Upside29.00% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
100
50.25%
Underperform Votes
99
49.75%
Avg. Outperform Votes
166
66.67%
Avg. Underperform Votes
83
33.33%
Avg. Outperform Votes
852
68.38%
Avg. Underperform Votes
394
31.62%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/20/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$27.75+8.95%
9/20/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jessica Tassan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$26.00 ➝ $27.75+8.95%
9/7/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$27.75+11.63%
6/20/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set Target$27.75+20.86%
6/3/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Daniels
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
5/31/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$25.75 ➝ $27.75+16.60%
5/26/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Davis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
8/31/2021Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeBuy$25.75+18.55%
2/10/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral
1/11/2021Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$23.00 ➝ $25.75+6.67%
1/7/2021Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Halper
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$25.75+7.65%
1/7/2021Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight
1/7/2021Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
1/7/2021Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Sector Perform$25.75+8.56%
1/6/2021Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
1/6/2021Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
1/6/2021Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeStrong-Buy ➝ Market Perform
9/28/2020CSFB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$16.00 ➝ $19.00+31.22%
7/6/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$15.00+36.74%
6/5/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$15.00 ➝ $17.00+39.69%
4/9/2020Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$18.00 ➝ $14.00+33.59%
3/18/2020The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Robert Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
(Data available from 10/5/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CHNG Price Target - Frequently Asked Questions

What is Change Healthcare's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Change Healthcare stock is Hold based on the current 5 hold ratings and 1 buy rating for CHNG. The average twelve-month price prediction for Change Healthcare is $27.75 with a high price target of $27.75 and a low price target of $27.75. Learn more on CHNG's analyst rating history.

Do Wall Street analysts like Change Healthcare more than its competitors?

Analysts like Change Healthcare less than other Medical companies. The consensus rating for Change Healthcare is Hold while the average consensus rating for medical companies is Buy. Learn more on how CHNG compares to other companies.

Do MarketBeat users like Change Healthcare more than its competitors?

MarketBeat users like Change Healthcare less than other Medical companies. 50.25% of MarketBeat users gave Change Healthcare an outperform vote while medical companies recieve an average of 66.67% outperform votes by MarketBeat users.

Is Change Healthcare being downgraded by Wall Street analysts?

Over the previous 90 days, Change Healthcare's stock had 2 downgrades by analysts.

Does Change Healthcare's stock price have much upside?

According to analysts, Change Healthcare's stock has a predicted upside of 12.42% based on their 12-month price targets.

What analysts cover Change Healthcare?

Change Healthcare has been rated by Citigroup, Piper Sandler, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CHNG) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.